We and others have recently shown that KRAS mutations are connected to an enhanced dependency on one-carbon metabolism (1CM) in non-small cell lung cancer (NSCLC) and colorectal cancer [17,18,19]. Here, KRAS is linked to non-small cell lung carcinoma.